Mengmei Wang

机构：Shanghai University of Medicine and Health Sciences, Health Data Research UK, University College London · ORCID：0009-0006-1243-7551

发表论文 15 篇 · 总被引 291 次 · h-index 8

代表论文

• A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial (2020 · Virologica Sinica · 被引 82)
• Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial (2020 · Clinical Infectious Diseases · 被引 58)
• Dexmedetomidine alleviates ferroptosis following hepatic ischemia-reperfusion injury by upregulating Nrf2/GPx4-dependent antioxidant responses (2023 · Biomedicine & Pharmacotherapy · 被引 48)
• Repurposed Tocilizumab in Patients with Severe COVID-19 (2020 · The Journal of Immunology · 被引 26)
• <p>Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China</p> (2020 · International Journal of COPD · 被引 26)
• Identification of a super-spreading chain of transmission associated with COVID-19 (2020 · medRxiv · 被引 22)